Home / Clusters / i-Health Innovative Medicine / Groups / NFCM /
Español     RSS

NFCM

Neuropharmacology of motivated behaviors

patents

Patents

  • 13/981,554 . 1,2,4-oxadiazole derivatives as drugs modulating the GLP-1 peptide receptor
    Scope: International
    Inventors: Fernando Rodríguez de Fonseca; Miguel Romero Cuevas, Laura Orío Ortiz, Juan Manuel Decara del Olmo, Mónica Alonso
    Year: 2013
    License: No


TopTop

Group web
Contact NFCM
Members
6


Group image
Head:
FERNANDO RODRIGUEZ DE FONSECA
RAQUEL GOMEZ DE HERAS

UCM reference: UCM962049

Keywords:

addiction.

feeding.

endocannabinoids and acylethanolamides.

drugs of abuse.

neuroinflammation.

animal behavior.

psychopharmacology.

obesity.

alcoholism.






News of the cluster


  1. Advances in models for early prediction of crises in chronic diseases
  2. International Mentor Program (IMP) USA-Europe
  3. First direct evidence for ultra-fast responses in human amygdala to fear
  4. Open call MIT-Spain - CEI Moncloa Seed Fund
  5. Videogames against malaria: learn through playing A Malaria "Candy Crush" to research new diagnostic tools involving citizen participation.


Ministry of Education, Culture & Sports CEI Campus of International Excellence Ministry of Economy & Competitiveness
Funded project by the Ministry of Education, Culture & Sports, and the Ministry of Economy & Competitiveness within the framework of the Campus of International Excellence
Navigating this website constitutes acceptance of the use of cookies by third parties and own, necessary for proper operation.